ATE189742T1 - Test zur diagnose von demenz - Google Patents

Test zur diagnose von demenz

Info

Publication number
ATE189742T1
ATE189742T1 AT96931219T AT96931219T ATE189742T1 AT E189742 T1 ATE189742 T1 AT E189742T1 AT 96931219 T AT96931219 T AT 96931219T AT 96931219 T AT96931219 T AT 96931219T AT E189742 T1 ATE189742 T1 AT E189742T1
Authority
AT
Austria
Prior art keywords
dementia
platelet
individual
sample
test
Prior art date
Application number
AT96931219T
Other languages
English (en)
Inventor
Meir Shinitzky
Michael Deckmann
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE189742T1 publication Critical patent/ATE189742T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Eye Examination Apparatus (AREA)
AT96931219T 1995-09-29 1996-09-26 Test zur diagnose von demenz ATE189742T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11546595A IL115465A0 (en) 1995-09-29 1995-09-29 Assay for the diagnosis of dementia
PCT/IL1996/000118 WO1997013152A1 (en) 1995-09-29 1996-09-26 Assay for the diagnosis of dementia

Publications (1)

Publication Number Publication Date
ATE189742T1 true ATE189742T1 (de) 2000-02-15

Family

ID=11068036

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96931219T ATE189742T1 (de) 1995-09-29 1996-09-26 Test zur diagnose von demenz

Country Status (8)

Country Link
US (1) US20030096227A1 (de)
EP (1) EP0856158B1 (de)
AT (1) ATE189742T1 (de)
AU (1) AU6999296A (de)
CA (1) CA2233321A1 (de)
DE (1) DE69606651T2 (de)
IL (2) IL115465A0 (de)
WO (1) WO1997013152A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122490A0 (en) * 1997-12-07 1998-06-15 Yeda Res & Dev Assay for schizophrenia based on skin reaction
WO2006040153A2 (en) * 2004-10-13 2006-04-20 Ablynx N.V. Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
CN101379399A (zh) * 2005-12-22 2009-03-04 罗姆股份有限公司 免疫测定装置和方法
US8492098B2 (en) 2006-02-21 2013-07-23 The Trustees Of Tufts College Methods and arrays for target analyte detection and determination of reaction components that affect a reaction
US11237171B2 (en) 2006-02-21 2022-02-01 Trustees Of Tufts College Methods and arrays for target analyte detection and determination of target analyte concentration in solution
US9012237B2 (en) * 2009-11-17 2015-04-21 Servicios Cientificos Neuroinnovation Limitada Innovative blood platelets biomarker for early diagnosis of alzheimer's disease
WO2011109379A1 (en) 2010-03-01 2011-09-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
US9952237B2 (en) 2011-01-28 2018-04-24 Quanterix Corporation Systems, devices, and methods for ultra-sensitive detection of molecules or particles
WO2012142301A2 (en) 2011-04-12 2012-10-18 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
WO2014113502A1 (en) 2013-01-15 2014-07-24 Quanterix Corporation Detection of dna or rna using single molecule arrays and other techniques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007922D0 (en) * 1990-04-07 1990-06-06 Oxford Virology Plc A diagnostic test method
AU669493B2 (en) * 1991-11-12 1996-06-13 University Of Melbourne, The A method for assaying and treating Alzheimer's disease
IL107515A (en) * 1993-11-05 1997-01-10 Yeda Res & Dev Diagnosis of mental disorders
JPH09510012A (ja) * 1994-03-01 1997-10-07 イエダ リサーチ アンド テベロツプメント カンパニー リミテツド 精神分裂病の診断のためのアッセイ

Also Published As

Publication number Publication date
IL123247A0 (en) 1998-09-24
WO1997013152A1 (en) 1997-04-10
IL115465A0 (en) 1995-12-31
DE69606651D1 (de) 2000-03-16
AU6999296A (en) 1997-04-28
EP0856158B1 (de) 2000-02-09
US20030096227A1 (en) 2003-05-22
EP0856158A1 (de) 1998-08-05
DE69606651T2 (de) 2000-06-15
CA2233321A1 (en) 1997-04-10

Similar Documents

Publication Publication Date Title
Johnson et al. The τ protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments
ATE128183T1 (de) Peptide und antikörper, die die bindung von blutplättchen verhindern.
ATE530671T1 (de) Verbindungen und verfahren zur diagnose von tuberkulose
NO170128C (no) Fremgangsmaate for dannelse av et monoklonalt antistoff for anvendelse som et diagnostisk posisjonsspesifikt reagens
ATE189742T1 (de) Test zur diagnose von demenz
ATE339680T1 (de) Verfahren und vorrichtung zur quantitativen bestimmung von teilchen in flüssigkeiten
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
DE69429192D1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
ATE163481T1 (de) Charakterisierung von störungen der blutplättchenaggregation
DE69941627D1 (de) Für krebs
CN101981452A (zh) 肺炎球菌检测方法
DE69032112D1 (de) Verfahren zur Isolierung von fetalen Zytotrophoblastzellen
CA2274776A1 (en) Method for analyzing annexin v in urine and use thereof
EP0386854B1 (de) Immunologische Bestimmung eines Gerinnungsfaktors in einer Probe
MY106963A (en) Agglutination assay.
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
Levine et al. Fast ELISA for measuring serum antibody responses
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
JPS5994068A (ja) 血中膵ラ氏島細胞膜抗体のロゼット形成法による検出法
FI104219B1 (fi) Diagnostinen menetelmä ja testaustarvikesarja multippeliskleroosin määrittämiseksi
ATE389175T1 (de) Verfahren zur prüfung von antigenen, die mit durch mentalen stress bedingten erkrankungen assoziiert sind
Lown et al. Application of the proteolytic enzyme papain in routine platelet serology
DE3853315D1 (de) Verfahren zur quantitativen Bestimmung von Serumproteinen in Körperflüssigkeiten und Mittel zur Durchführung des Verfahrens.
ATE491945T1 (de) Verfahren zur bestimmung des vorhandenseins von thrombozyteninhibitoren in einer blutprobe
HUT60039A (en) Method for detecting allergy to food proteins and screening test set applicable for said method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties